2-[[6-Hydroxy-15-[6-hydroxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-7,7,12,16-tetramethyl-14-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-methyloxane-3,4,5-triol
| Internal ID | eac34d16-8b39-4bd2-82dc-3753649177c4 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins > Cucurbitacin glycosides |
| IUPAC Name | 2-[[6-hydroxy-15-[6-hydroxy-6-methyl-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-2-yl]-7,7,12,16-tetramethyl-14-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-methyloxane-3,4,5-triol |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C48H82O19/c1-20(9-10-28(44(5,6)61)67-42-38(60)35(57)32(54)25(18-50)66-42)29-23(64-41-37(59)34(56)31(53)24(17-49)65-41)16-46(8)26-15-22(63-40-36(58)33(55)30(52)21(2)62-40)39-43(3,4)27(51)11-12-48(39)19-47(26,48)14-13-45(29,46)7/h20-42,49-61H,9-19H2,1-8H3 |
| InChI Key | WCJMPVBZXRBMHR-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C48H82O19 |
| Molecular Weight | 963.20 g/mol |
| Exact Mass | 962.54503038 g/mol |
| Topological Polar Surface Area (TPSA) | 318.00 Ų |
| XlogP | 0.30 |
| Atomic LogP (AlogP) | -1.22 |
| H-Bond Acceptor | 19 |
| H-Bond Donor | 13 |
| Rotatable Bonds | 13 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4805 | 48.05% |
| Caco-2 | - | 0.8766 | 87.66% |
| Blood Brain Barrier | - | 0.5750 | 57.50% |
| Human oral bioavailability | - | 0.8286 | 82.86% |
| Subcellular localzation | Mitochondria | 0.5846 | 58.46% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8665 | 86.65% |
| OATP1B3 inhibitior | + | 0.9122 | 91.22% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.5750 | 57.50% |
| BSEP inhibitior | - | 0.7791 | 77.91% |
| P-glycoprotein inhibitior | + | 0.7585 | 75.85% |
| P-glycoprotein substrate | + | 0.5636 | 56.36% |
| CYP3A4 substrate | + | 0.7139 | 71.39% |
| CYP2C9 substrate | - | 0.8018 | 80.18% |
| CYP2D6 substrate | - | 0.8301 | 83.01% |
| CYP3A4 inhibition | - | 0.9472 | 94.72% |
| CYP2C9 inhibition | - | 0.7996 | 79.96% |
| CYP2C19 inhibition | - | 0.8391 | 83.91% |
| CYP2D6 inhibition | - | 0.9505 | 95.05% |
| CYP1A2 inhibition | - | 0.8918 | 89.18% |
| CYP2C8 inhibition | + | 0.6237 | 62.37% |
| CYP inhibitory promiscuity | - | 0.9671 | 96.71% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.9700 | 97.00% |
| Carcinogenicity (trinary) | Non-required | 0.6868 | 68.68% |
| Eye corrosion | - | 0.9895 | 98.95% |
| Eye irritation | - | 0.9040 | 90.40% |
| Skin irritation | - | 0.7152 | 71.52% |
| Skin corrosion | - | 0.9483 | 94.83% |
| Ames mutagenesis | - | 0.7137 | 71.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7482 | 74.82% |
| Micronuclear | - | 0.8000 | 80.00% |
| Hepatotoxicity | - | 0.7218 | 72.18% |
| skin sensitisation | - | 0.9113 | 91.13% |
| Respiratory toxicity | - | 0.5333 | 53.33% |
| Reproductive toxicity | + | 0.7444 | 74.44% |
| Mitochondrial toxicity | - | 0.5875 | 58.75% |
| Nephrotoxicity | - | 0.8761 | 87.61% |
| Acute Oral Toxicity (c) | I | 0.6066 | 60.66% |
| Estrogen receptor binding | + | 0.7139 | 71.39% |
| Androgen receptor binding | + | 0.7529 | 75.29% |
| Thyroid receptor binding | - | 0.5362 | 53.62% |
| Glucocorticoid receptor binding | + | 0.6023 | 60.23% |
| Aromatase binding | + | 0.6450 | 64.50% |
| PPAR gamma | + | 0.7308 | 73.08% |
| Honey bee toxicity | - | 0.6210 | 62.10% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.6100 | 61.00% |
| Fish aquatic toxicity | + | 0.8024 | 80.24% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.96% | 91.11% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.81% | 97.25% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.91% | 97.09% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 94.84% | 96.61% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 93.76% | 96.09% |
| CHEMBL240 | Q12809 | HERG | 92.76% | 89.76% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 92.51% | 97.79% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 92.48% | 95.93% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 92.45% | 91.49% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 90.76% | 92.86% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 90.42% | 96.21% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 89.45% | 97.31% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 89.30% | 92.50% |
| CHEMBL4105786 | P41182 | B-cell lymphoma 6 protein | 89.21% | 92.86% |
| CHEMBL1977 | P11473 | Vitamin D receptor | 88.50% | 99.43% |
| CHEMBL2581 | P07339 | Cathepsin D | 87.78% | 98.95% |
| CHEMBL1741186 | P51449 | Nuclear receptor ROR-gamma | 87.40% | 99.17% |
| CHEMBL3837 | P07711 | Cathepsin L | 87.27% | 96.61% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 87.21% | 99.17% |
| CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 86.91% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 86.73% | 95.89% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 86.53% | 95.58% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.50% | 89.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 86.11% | 96.47% |
| CHEMBL241 | Q14432 | Phosphodiesterase 3A | 85.92% | 92.94% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 85.22% | 94.45% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 85.19% | 94.75% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 85.10% | 100.00% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 84.39% | 90.24% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 84.24% | 90.17% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.31% | 100.00% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 83.30% | 98.10% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 83.15% | 95.38% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 83.05% | 86.33% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.02% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.96% | 93.56% |
| CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 82.87% | 92.78% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.83% | 95.50% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 82.65% | 97.64% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 82.19% | 96.95% |
| CHEMBL1293255 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD+] | 81.51% | 83.57% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 81.42% | 82.50% |
| CHEMBL203 | P00533 | Epidermal growth factor receptor erbB1 | 80.85% | 97.34% |
| CHEMBL4805 | Q99572 | P2X purinoceptor 7 | 80.83% | 97.50% |
| CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 80.52% | 97.36% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 80.30% | 95.83% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 80.27% | 90.08% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 80.25% | 98.05% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 80.23% | 95.69% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.14% | 98.75% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Astragalus amblolepis |
| PubChem | 162883086 |
| LOTUS | LTS0049743 |
| wikiData | Q105301806 |